Hemoglobin variability in epoetin-treated hemodialysis patients.

@article{Berns2003HemoglobinVI,
  title={Hemoglobin variability in epoetin-treated hemodialysis patients.},
  author={Jeffrey S. Berns and Hafez Elzein and Robert I Lynn and Steven A Fishbane and Ira S Meisels and Peter B Deoreo},
  journal={Kidney international},
  year={2003},
  volume={64 4},
  pages={1514-21}
}
BACKGROUND Understanding the clinical variability of hemoglobin measurements in epoetin-treated hemodialysis patients is important, particularly when this therapy is aimed at maintaining patient hemoglobin levels within a narrow range, such as the 11 to 12 g/dL range recommended in National Kidney Foundation Kidney Dialysis Outcomes Quality Initiative (NKF-K/DOQI) guidelines. This study examines hemoglobin variability under conditions of standard clinical practice in epoetin-treated… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 58 extracted citations

Comparison of the therapeutic effects of two recombinant erythropoietin beta , biosimilar and reference formulations in patients with chronic kidney disease under hemodialysis

Maria del Carmen Popoca-Martínez, Julio Flores-Garnica, Odette Díaz-Avendaño, Emmanuel Canales-Vázquez, Raúl Meixueiro-Montes De Oca
2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Effect of variability in anemia management on hemoglobin outcomes in ESRD

E Lacson, Jr., N Ofsthun, JM Lazarus
Am J Kidney Dis 41:111–124, • 2003
View 5 Excerpts
Highly Influenced

Can evidence drive the development of a sound national EPO reimbursement policy?

American journal of kidney diseases : the official journal of the National Kidney Foundation • 2003
View 2 Excerpts
Highly Influenced

Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation • 2002
View 2 Excerpts

Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2001
View 1 Excerpt

Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level.

American journal of kidney diseases : the official journal of the National Kidney Foundation • 2001
View 1 Excerpt

Haemoglobin, not haematocrit, should be the preferred parameter for the evaluation of anaemia in renal patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2001
View 1 Excerpt

European best practice guidelines 5: target haemoglobin.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2000
View 2 Excerpts

Similar Papers

Loading similar papers…